510(k) Report

510(k) · Cleared

Cleared

Neuronav System and Neuronav Drive

K071697510(k) TraditionalCleared Dec 3, 2007166-day reviewClass II21 CFR 882.1330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alpha Omega, Ltd. · GZL Electrode, Depth

Cleared on Dec 3, 2007 after a 166-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 3 later devices descend from it.

Decided
Dec 3, 2007
Review
166 days
Class
Class II
Product code
GZL
Recalls
None
Predicates
0

3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2018: 1 descendant cleared2022: 1 descendant cleared2025: 1 descendant cleared20052010201520202025
  1. This deviceK071697 Neuronav System and Neuronav DriveAlpha Omega, Ltd. · 2007
  2. Descendant · cites it directly · 2 of its ownK172042 NeuroNav System, NeuroSmart SystemAlpha Omega Engineering, Ltd. · 2018
  3. Descendant · 2 generations on · 1 of its ownK220553 Neuro Omega System, NeuroSmart SystemAlpha Omega Engineering, Ltd. · 2022
  4. Descendant · 3 generations on · 0 of its ownK250601 Neuro Omega System; NeuroSmart SystemAlpha Omega Engineering, Ltd. · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K172042NeuroNav System, NeuroSmart SystemAlpha Omega Engineering, Ltd. · 2018 · cites it directly2descendants
  • K220553Neuro Omega System, NeuroSmart SystemAlpha Omega Engineering, Ltd. · 2022 · 2 generations on1descendant
  • K250601Neuro Omega System; NeuroSmart SystemAlpha Omega Engineering, Ltd. · 2025 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K071697Neuronav System and Neuronav DriveAlpha Omega, Ltd.2007—
+1K172042NeuroNav System, NeuroSmart SystemAlpha Omega Engineering, Ltd.2018—
+2K220553Neuro Omega System, NeuroSmart SystemAlpha Omega Engineering, Ltd.2022—
+3K250601Neuro Omega System; NeuroSmart SystemAlpha Omega Engineering, Ltd.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
202210
202510
FIG. 1 — Lineage of K071697, 2007–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZL device

  1. #1 K253970 Wovyn Depth Electrodescore 13.3 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172042NeuroNav System, NeuroSmart SystemAlpha Omega Engineering, Ltd.20182

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K172042 (Alpha Omega Engineering, Ltd., 2018) has gone furthest, with 2 descendants of its own.

How does its category compare?

All GZL devices

GZL Electrode, Depth: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GZL

2in 2025

2007: 32009: 12011: 12012: 12013: 12014: 12016: 22017: 42018: 32020: 12021: 32022: 32023: 32025: 22026 (partial year): 1
2007high 4 (2017) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZL

206in 2023

2007: 166 days median2017: 222 days median2018: 58 days median2021: 262 days median2022: 90 days median2023: 206 days median
2007high 262 (2021) · low 58 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZL

3in 2024

2008: 32009: 22014: 12021: 92024: 3
2007high 9 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZL

12in 2025

2008: 82009: 52010: 62011: 42012: 82013: 252014: 72015: 142016: 92017: 32018: 22019: 132020: 242021: 132022: 102023: 302024: 162025: 12
2007high 30 (2023) · low 0 (2007)2025

MAUDE reports naming product code GZL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007316600
20080—38
20091—25
20100—06
20111—04
20121—08
20131—025
20141—17
20150—014
20162—09
2017422203
201835802
20190—013
20201—024
20213262913
2022390010
20233206030
20240—316
20252—012
20261—0—
Cite this page

510(k) Report. “K071697: Neuronav System and Neuronav Drive.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K071697

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026